Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • AcoBetalow
    Junior Member
    • Nov 2014
    • 4

    Amplification free library preparation

    Hello community,

    Firstly I would like to greet everyone, for this is my first of hopefully many productive experiences on this forum.

    My question involves amplification free library preparation for MiSeq. We have purified aptamers of 80 bp and would like to prepare them for sequencing with as little amplification as possible.

    Is it possible to directly ligate indexes to aptamers are do we have to ligate adapters first?

    Is there any other way?

    Thank you in advance for any suggestions.
  • jlei_face
    Member
    • Oct 2014
    • 10

    #2
    The ligation of adapters (which contain your index) occurs right before amplification so as long as you have enough material/high enough library yield for clustering you don't necessarily need to amplify.

    Comment

    • Asaf
      Member
      • Jul 2014
      • 20

      #3
      Alternatively, you can use UMI - unique molecule identifiers. Each adapter that you ligate contains abarcode (of the library) and a short sequence (4-6 nt) unique for that molecule. After amplification you count each UMI of each DNA species only once, even if you got multiple reads of it and overcome amplification bias.
      Another amplification with less bias is IVT - in-vitro transcription which is linear rather than exponential as in PCR.

      Comment

      • AcoBetalow
        Junior Member
        • Nov 2014
        • 4

        #4
        Firstly, thank you for your help.

        After wavering few possibilities, we have decided that probably easiest and cost effective way is to use cloning kit to repair ends of the aptamers, create single d-ATP overhangs on 3' end and ligate adapters to them. Afterwards we made compromise and we will use standard Illumina index PCR to label.

        Another solution is KAPA hyper prep kit, that ligates adapters and indexes all together, but is a bit more expensive.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        210 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...